IART Actualités Forex
Integra LifeSciences To Acquire Acclarent For $275 Mln Cash
Medical technology firm Integra LifeSciences Holdings Corp. (IART) announced Wednesday that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company, for $275 million in cash at closing. This is subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones.
RTTNews
|
il y a 322
Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates
While reporting financial results for the second quarter on Wednesday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2022. The company also issued outlook for the third quarter.
RTTNews
|
il y a 826
